Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
How do you use serum IgG levels when treating with FcRN inhibitors?
Related to
previous question on dosing of rozanolixizumab
Related Questions
How do you adjust dosing of rozanolixizumb for MG patients who deteriorate before the minimum re-dosing period?
Which non-pharmacologic treatments for neuropathic pain have you found most effective?
What is your approach to patients with diffuse, patchy paresthesias affecting the head, face, lips, and/or tongue?
Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?
How do you approach patients with positive LRP4 antibodies without clinical findings of myasthenia gravis?
Do you consider immunosuppression in patients with a history of Sjogren's disease and clinical features of inclusion body myositis?
How do you counsel patients on the benefits of immunotherapy for anti-MAG neuropathy?
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
What is the stepwise investigation of patients suspected of inflammatory myopathy?
When do you consider ultrahigh-dose methylcobalamin injections for ALS?
